MedPath

exercise training and adipokines

Not Applicable
Conditions
Insulin resistance.
Diabetes mellitus, Obesity and other hyperalimentation
E10, E11,
Registration Number
IRCT2012090210709N1
Lead Sponsor
Vice Chancellor for Research of Alzahra University
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Complete
Sex
Female
Target Recruitment
24
Inclusion Criteria

45-60 years old women; postmenopausal; obese (BMI>30 kg/m2); healthy (without no history of diabetes, cardiovascular and neurological diseases); sedentary
Exclusion criteria: women younger than 45 and older than 60; non- menopausal; not obese; with disease effecting on process and result of study; athletes

Exclusion Criteria

Not provided

Study & Design

Study Type
interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
eptin. Timepoint: befor and after 48 hours after. Method of measurement: elisa.;Adiponectin. Timepoint: before and 48 hours after training. Method of measurement: elisa.
Secondary Outcome Measures
NameTimeMethod
Insulin resistance index (HOMA-IR). Timepoint: before and 48 hours after training. Method of measurement: Fasting serum glucose concentrations were measured by glucose oxidase method using a Beckman Glucose Analyzer (Beckman Instruments, Irvine, CA). Insulin was measured by radioimmunoassay with commercial kits (Immuno Nucleo, Stillwater, MN). The homeostasis model assessment of insulin resistance (HOMA-IR) was calculated using the HOMA-IR equation: [fasting insulin (µU/mL) × fasting glucose (mmol/L)/ 18]/ 22.5.
© Copyright 2025. All Rights Reserved by MedPath